Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of$ 0.24. This compares to loss of $0.26 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this maker of genetic analysis technology would post a loss of$ 0.26 per share when it actually produced a loss of $0.26, delivering no surprise. Over the last ...